4,180 reports of this reaction
7.2% of all ABALOPARATIDE reports
#1 most reported adverse reaction
HEADACHE is the #1 most commonly reported adverse reaction for ABALOPARATIDE, manufactured by Radius Health, Inc.. There are 4,180 FDA adverse event reports linking ABALOPARATIDE to HEADACHE. This represents approximately 7.2% of all 58,437 adverse event reports for this drug.
Patients taking ABALOPARATIDE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among ABALOPARATIDE users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for ABALOPARATIDE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 4,180 FDA reports for ABALOPARATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 7.2% of all adverse event reports for ABALOPARATIDE, making it one of the most commonly reported side effect.
If you experience headache while taking ABALOPARATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.